HETLIOZ LQ

Indicated For

Nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Non-24-Hour Sleep-Wake Disorder

About This Medication

# HETLIOZ Solutions Patient Assistance Program Patient Guide: How to Get HETLIOZ LQ (tasimelteon) at Low or No Cost HETLIOZ LQ (tasimelteon) is a prescription medication designed to help adults with **Non-24-Hour Sleep-Wake Disorder (Non-24)**, a condition where the body's internal clock doesn't align with the 24-hour day, often causing sleep problems in people who are totally blind. The **HETLIOZ Solutions Patient Assistance Program** from Vanda Pharmaceuticals helps eligible patients access this treatment at low or no cost through financial support, insurance navigation, and home delivery coordination.[1][3][8] ## About HETLIOZ LQ and Non-24 **Non-24** affects about 80% of totally blind individuals because they can't detect light cues that reset the body's circadian rhythm. This leads to cycles of poor sleep, daytime sleepiness, and nighttime wakefulness that shift daily. HETLIOZ LQ, the liquid form of tasimelteon, is taken once nightly at the same time (ideally 1 hour before bedtime) to help entrain the body's clock and improve nighttime sleep. It's FDA-approved specifically for Non-24 in adults and works by mimicking melatonin to regulate sleep-wake cycles. Unlike over-the-counter sleep aids, it's tailored for this circadian disorder.[1][3][4] Common side effects include headache, elevated liver enzymes, nightmares, or infections, but it's generally well-tolerated. Always consult your doctor to see if it's right for you. HETLIOZ Solutions provides **educational resources** alongside medication access to help you understand your condition and treatment.[3] ## Who Qualifies for the Program? The program supports **underinsured, uninsured, or commercially insured patients** diagnosed with Non-24. It offers a range of financial assistance, including a **Patient Assistance Program (PAP)** for those who qualify based on income. Vanda is committed to accessibility, pairing you with a **Patient Care Coordinator** for personalized help from prescription to delivery.[1][3][8] Eligibility focuses on: - Confirmed Non-24 diagnosis from your healthcare provider (HCP). - U.S. residency (program is U.S.-based).[4] - Insurance status: Works for commercial insurance (co-pay help), underinsured, or uninsured.[8] ## Income Eligibility Breakdown The **free medication PAP** is income-based, but exact thresholds (e.g., Federal Poverty Level percentage) are **not publicly disclosed**—details are shared privately with patients during eligibility screening to protect privacy. This ensures a tailored assessment.[8] Here's a general overview of how pharmaceutical PAPs like this typically work (based on program structure): | Household Size | Typical FPL Threshold Range* | Notes | |---------------|------------------------------|-------| | **Individual** | Up to 400-500% FPL | Exact % disclosed privately[8] | | **Couple** | Up to 400-500% FPL | Adjusted for household income[8] | | **Family of 3** | Up to 400-500% FPL | Includes dependents[8] | | **Family of 4+** | Up to 400-500% FPL | Call for precise calculation | *FPL = Federal Poverty Level (e.g., 2026 guidelines: ~$15,060 individual). Program verifies via financial docs. Income includes household total; assets may factor in.[5][8] Your coordinator will review pay stubs, tax returns, etc., confidentially. Even if income is above PAP limits, other **co-pay mitigation** options may apply.[2] ## Insurance Requirements - **Commercially insured**: Get co-pay cards or coverage help to reduce out-of-pocket costs. - **Underinsured**: Bridge gaps in coverage. - **Uninsured**: Qualify for free meds via PAP if income-eligible. **Medicare/Medicaid patients may not qualify** for PAP (federal rules prohibit), but coordinators assist with alternatives like specialty pharmacy prior authorizations.[3][8] HETLIOZ Solutions reviews your benefits one-on-one.[1] ## Step-by-Step Application Process 1. **Contact HETLIOZ Solutions**: You or your doctor call **(844) 438-5469** (1-844-HETLIOZ), Mon-Fri 9AM-8PM ET. Expect an **introduction call within 24 hours**.[1][2][8] 2. **Get Assigned a Coordinator**: They'll explain enrollment, answer insurance questions, and guide financial eligibility.[3] 3. **Complete Prescription & Service Request Form**: Your HCP fills this out (download from hetliozpro.com). Includes authorization for Vanda/RxCrossroads to handle your info for assistance programs.[2] 4. **Submit Documents**: Fax form to (844) 364-2424. Provide **insurance info** (card, coverage details) and financial docs for PAP (e.g., 1099s, W-2s).[2][5][8] 5. **Eligibility Review**: Coordinator verifies insurance/finances. Info goes to **specialty pharmacy** for final setup.[8] 6. **Approval & Start**: Receive status letter. Meds ship to your door.[5][8] Application methods are **multiple** (phone, fax, coordinator-led).[8] ## Timeline and Delivery - **Initial contact to coordinator**: Within 24 hours.[2] - **Processing**: Varies; status letter sent soon after docs received. Call for updates.[5] - **Delivery**: Via **specialty pharmacy home delivery**. Coordinators handle refills, reminders, adherence support.[3][8] Expect meds within days to weeks post-approval, depending on insurance.[1] ## Alternatives if Denied - **Other Vanda programs**: Co-pay help if income too high for PAP.[2] - **Non-Vanda assistance**: Coordinator refers to independent PAPs.[2][5] - **Appeals**: Resubmit updated docs or call for review.[8] - **Generic/biosimilars**: None available for tasimelteon.[8] - **Patient advocacy**: Groups like RxAssist.org list options.[9] ## Important Disclaimer This guide is for informational purposes based on publicly available program details as of 2026. Eligibility, terms, and availability can change—**always verify directly with HETLIOZ Solutions at (844) 438-5469**. Not medical advice; consult your HCP. Vanda/RxCrossroads may share your info for program operation. Free meds typically last 1 year, subject to re-verification. Program not for Medicare Part D.[1][2][5][8]

Program information last verified: March 30, 2026